MyAverix Finance MyAverix Finance

EGX

Alexandria Pharmaceuticals (AXPH)

Alexandria Pharmaceuticals (AXPH) is listed on EGX. As of 2026-05-21, reported P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Data as of 2026-05-21

Download on the App Store Get it on Google Play

Download free on iPhone and Android

Key metrics for AXPH

P/E ratio
18.00
Gross profit (TTM)
$0
Net margin
0.0%

Alexandria Pharmaceuticals (AXPH) — FAQ

What is AXPH's P/E ratio?

The price-to-earnings (P/E) ratio for Alexandria Pharmaceuticals (AXPH) is 18.00 (data as of 2026-05-21).

Does Alexandria Pharmaceuticals pay a dividend?

Dividend yield is not available in the current snapshot for Alexandria Pharmaceuticals (AXPH). Check the MyAverix Finance app for the latest dividend data.

What exchange is AXPH listed on?

AXPH is listed on EGX.

What is Alexandria Pharmaceuticals's net margin?

Alexandria Pharmaceuticals (AXPH) reports a net margin of 0.0% (data as of 2026-05-21).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

← All stocks

MyAverix Finance provides company information and financial data for educational and research purposes only. We are not a broker, advisor, or investment service. Data may be delayed or incomplete. Past performance does not guarantee future results. Always do your own research before making financial decisions.

Terms of Use

App Store Google Play